Novel substances

In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor

Pottie, E., Cannaert, A., & Stove, C. P | Archives of Toxicology | 5 July 2020

In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation.

Berquist, M. D., Leth-Petersen, S., Kristensen, J. L., & Fantegrossi, W. E. | Drug and Alcohol Dependence | 13 January 2020

From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner.

Kettner, H., Gandy, S., Haijen, E. C., & Carhart-Harris, R. L. | International Journal of Environmental Research and Public Health | 16 December 2019

Locomotor effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in mice: psychostimulant effects, stereotypy, and sensitization

Berquist, M. D., Leth-Petersen, S., Kristensen, J. L., & Fantegrossi, W. E. | Psychopharmacology | 15 Nov 2019

Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice.

Oppong-Damoah, A., Curry, K. E., Blough, B. E., Rice, K. C., & Murnane, K. S. | Psychopharmacology | 15 July 2019

Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).

Brandt, S. D., Kavanagh, P. V., Westphal, F., Stratford, A., Elliott, S. P., Dowling, G., ... & Halberstadt, A. L. | Drug testing and analysis | 18 June 2018

Emerging from the dark side: new therapeutic applications of scheduled psychoactive substances

James, E., Robertshaw, T. L., & Westwell, A. D. | Future Medicinal Chemistry | 14 February 2019

Self-Experiments with Psychoactive Substances: A Historical Perspective

Passie, T., & Brandt, S. D. | Handbook of Experimental Pharmacology | 27 November 2018

Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.

Kivell, B., Paton, K., Kumar, N., Morani, A., Culverhouse, A., Shepherd, A., ... & Prisinzano, T. | Molecules | 11 October 2018

The epidemiology of 5-methoxy- N,N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption

Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. | Journal of Psychopharmacology | 30 April 2018

The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption

Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. | Journal of Psychopharmacology | 30 April 2018

Acute pharmacological effects of 2C-B in humans: An observational study

Papaseit, E., Farré, M., Perez-Maña, C., Torrens, M., Ventura, M., Pujadas, M., ... & González, D. | Frontiers in Pharmacology | 13 March 2018

Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats

Elmore, J. S., Decker, A. M., Sulima, A., Rice, K. C., Partilla, J. S., Blough, B. E., & Baumann, M. H. | Neuropharmacology | 1 March 2018

Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice

Buchborn, T., Lyons, T., & Knöpfel, T. | Frontiers in Pharmacology | 6 Februari 2018

The ‘Endless Trip’: Psychopathology and Psychopharmacology in the Hallucinogen Persisting Perception Disorder/HPPD and the NPS. A systematic review

Orsolini, L., Papanti, G. D., De Berardis, D., Guirguis, A., Corkery, J. M., & Schifano, F. | Frontiers in Psychiatry | 20 November 2017

MDA, MDMA and other mescaline-like substances in the US military’s search for a truth drug (1940s to 1960s)

Passie, T., & Benzenhöfer, U. | Drug testing and analysis | 29 August 2017

Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs

Hassan, Z., Bosch, O. G., Singh, D., Narayanan, S., Kasinather, B. V., Seifritz, E., ... & Müller, C. P. | Frontiers in psychiatry | 18 August 2017

Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)

Luethi, D., Trachsel, D., Hoener, M. C., & Liechti, M. E. | Neuropharmacology | 15 July 2017

Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775)

Brandt, S. D., Kavanagh, P. V., Twamley, B., Westphal, F., Elliott, S. P., Wallach, J., ... & Halberstadt, A. L. | Drug Testing and Analysis | 5 June 2017

Genie in a blotter: A comparative study of LSD and LSD analogues’ effects and user profile

Coney, L. D., Maier, L. J., Ferris, J. A., Winstock, A. R., & Barratt, M. J. | Human Psychopharmacology: Clinical and Experimental | 18 May 2017

A single administration of the hallucinogen, 4-acetoxy-dimethyltryptamine, prevents the shift to a drug-dependent state and the expression of withdrawal aversions in rodents

Vargas‐Perez, H., Grieder, T. E., Ting‐A‐Kee, R., Maal‐Bared, G., Chwalek, M., & van der Kooy, D. | European Journal of Neuroscience | 4 May 2017